Clinical Trial Update: A Study of Herceptin (Trastuzumab) in Combination With Whole Brain Radiotherapy in Patients With HER-2 Positive Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 study evaluated trastuzumab (Herceptin) in combination with whole-brain radiotherapy for HER2-positive breast cancer. The trial was terminated and res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HERCEPTIN (trastuzumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2014-08-11